Aurinia Pharmaceuticals (AUPH) Earnings Date, Estimates & Call Transcripts → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free auph Stock Alerts $5.01 -0.02 (-0.40%) (As of 08:32 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 2Before Market OpensConfirmedActual EPS (Feb. 15) -$0.19 Missed By -$0.03 Consensus EPS (Feb. 15) -$0.16 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Aurinia Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for AUPH and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAUPH Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AUPH Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. Aurinia Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242($0.16)($0.14)($0.15) Q2 20242($0.08)$0.04($0.02) Q3 20242($0.08)$0.04($0.02) Q4 20242$0.02$0.17$0.10 FY 20248($0.30)$0.11 ($0.10)AUPH Earnings Date and InformationAurinia Pharmaceuticals last released its earnings data on February 15th, 2024. The biotechnology company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.16) by $0.03. The company earned $45.10 million during the quarter, compared to analysts' expectations of $45 million. Its quarterly revenue was up 58.8% compared to the same quarter last year. Aurinia Pharmaceuticals has generated ($0.54) earnings per share over the last year (($0.54) diluted earnings per share). Earnings for Aurinia Pharmaceuticals are expected to grow in the coming year, from ($0.06) to $0.55 per share. Aurinia Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Thursday, May 2nd, 2024. Aurinia Pharmaceuticals will be holding an earnings conference call on Thursday, May 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call.. Read More Aurinia Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/2/2024Confirmed)------- 2/15/2024Q4 2023($0.16)($0.19)($0.03)($0.19)$45.00 million$45.10 million 11/2/2023Q3 2023($0.17)($0.09)+$0.08($0.09)$38.41 million$54.52 million8/3/2023Q2 2023($0.20)($0.08)+$0.12($0.08)$37.90 million$41.49 million 5/4/2023Q1 2023($0.23)($0.18)+$0.05($0.18)$28.12 million$34.41 million 2/28/2023Q4 2022($0.26)($0.18)+$0.08($0.18)$28.82 million$28.40 million 11/3/2022Q3 2022($0.18)($0.06)+$0.12($0.06)$38.11 million$55.78 million Get the Latest News and Ratings for AUPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aurinia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022($0.22)($0.25)($0.03)($0.25)$27.07 million$28.19 million 5/10/2022Q1 2022($0.26)($0.27)($0.01)($0.27)$19.68 million$21.63 million 2/28/2022Q4 2021($0.26)($0.25)+$0.01($0.25)$22.43 million$23.40 million 11/2/2021Q3 2021($0.33)($0.39)($0.06)($0.39)$14.70 million$14.67 million 8/4/2021Q2 2021($0.35)($0.37)($0.02)($0.37)$4.98 million$6.62 million 5/5/2021Q1 2021($0.35)($0.40)($0.05)($0.40)$2.30 million$0.91 million Aurinia Pharmaceuticals Earnings - Frequently Asked Questions When is Aurinia Pharmaceuticals's earnings date? Aurinia Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Thursday, May 2nd, 2024. Learn more on AUPH's earnings history. Did Aurinia Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Aurinia Pharmaceuticals (NASDAQ:AUPH) missed the analysts' consensus estimate of ($0.16) by $0.03 with a reported earnings per share (EPS) of ($0.19). Learn more on analysts' earnings estimate vs. AUPH's actual earnings. How can I listen to Aurinia Pharmaceuticals's earnings conference call? The conference call for Aurinia Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Aurinia Pharmaceuticals's conference call transcript? The conference call transcript for Aurinia Pharmaceuticals's latest earnings report can be read online. Read Transcript How can I view Aurinia Pharmaceuticals's earnings report? Aurinia Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Aurinia Pharmaceuticals generate each year? Aurinia Pharmaceuticals (NASDAQ:AUPH) has a recorded annual revenue of $175.51 million. How much profit does Aurinia Pharmaceuticals generate each year? Aurinia Pharmaceuticals (NASDAQ:AUPH) has a recorded net income of -$78.02 million. AUPH has generated -$0.54 earnings per share over the last four quarters. What is Aurinia Pharmaceuticals's EPS forecast for next year? Aurinia Pharmaceuticals's earnings are expected to grow from ($0.06) per share to $0.55 per share in the next year. More Earnings Resources from MarketBeat Related Companies: IRON Earnings Results NRIX Earnings Results ALXO Earnings Results SVRA Earnings Results PRAX Earnings Results PHAR Earnings Results ELVN Earnings Results TYRA Earnings Results YMAB Earnings Results TNGX Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:AUPH) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurinia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
